Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,939.00
Bid: 1,938.00
Ask: 1,940.00
Change: 4.00 (0.21%)
Spread: 2.00 (0.103%)
Open: 1,938.00
High: 1,942.00
Low: 1,926.00
Prev. Close: 1,935.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

Fri, 08th Apr 2016 07:37

LONDON (Alliance News) - Shares in London were higher Friday morning, with resource stocks leading the gainers as the oil prices take back some of their Thursday losses.

The FTSE 100 was up 0.8%, or 50.59 points, at 6,187.48. In Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were up 0.6% and 0.5%, respectively.

"Oil prices continue to get excited by the April 17 Doha meeting despite a chance of a production freeze deal looking slim to say the least with Iran saying 'No' and Saudi Arabia saying 'Only with Iran'. Desire is there, but as in break-up speak 'it's complicated'," said Accendo Markets head of research Mike van Dulken.

Brent oil was at USD40.11 a barrel shortly after the London equities open, higher than the USD38.93 a barrel at the close on Thursday.

Investors will keep a close eye later Friday on the US Baker Hughes oil rig count, scheduled for after the London equities close at 1800 BST.

Resource stocks were among the best performers in the FTSE 100, with Anglo American up 2.7%, Glencore up 2.4%, Rio Tinto up 2.3% and BHP Billiton up 2.2%. Oil company BP was up 1.3%, while Royal Dutch Shell's 'A' shares were up 1.1%.

Also among risers was Vodafone Group, after Deutsche Bank added the telecommunications company to its Short Term Buy List, according to traders.

Banks were also brightly green, with Standard Chartered up 2.1%, Royal Bank of Scotland Group up 1.6% and Lloyds Banking Group up 1.2%.

European banking stocks were hit Thursday after the ECB minutes "appeared to leave the door open to further negative interest rates, despite fears from some members about the adverse impacts on bank profitability," said CMC Markets analyst Jasper Lawler.

In its meeting on March 10, the ECB cut the main refinancing rate, which the central bank uses to boost liquidity, by five basis points to a record low 0.0%. The already-negative deposit rate was cut by 10 basis points to -0.40%, while there was a surprise five-basis-point cut to its marginal lending facility rate to 0.25%.

In the accounts, the ECB policymakers said they decided that a limited cut was appropriate as prospect of further cut cannot be ruled out if the inflation outlook deteriorates. Governing Council members broadly supported a further cut in the deposit facility rate and stressed the importance of communication and the link to the formulation of forward guidance.

The euro was at USD1.1354 after the open Friday. The single currency hit a high of USD1.1453 on Thursday but retreated following the release of the ECB accounts, standing at USD1.1373 at the London equities close.

Information services company Experian was the worst blue-chip performer early Friday, down 1.0%, after being downgraded to Reduce from Buy by HSBC. Meanwhile, insurer Schroders was cut to Neutral from Outperform by Exane BNP, sending its shares down 0.2%.

The FTSE 250 was up 0.4% at 16,781.27, while the AIM All-Share was up 0.1% at 717.83.

Hikma Pharmaceuticals and Vectura Group said the new drug application for their fluticasone propionate and salmeterol inhalation powder has been accepted for filing by the Food & Drug Administration in the US.

The two pharmaceutical companies are working together on the inhalation powder, which is a generic version of GlaxoSmithKline's Advair Diskus, which is used to treat asthma and to maintain treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Shares in Hikma were up 1.0%, while Vectura Group was the best mid-cap performer, up 5.0%. In the FTSE 100, GlaxoSmithKline shares were down 0.1%.

At the other end of the FTSE 250, DFS Furniture was down 5.3% at 303.20 pence. Private equity firm Advent International said it agreed to sell a 14.1% stake in the sofa retailer for GBP90.0 million. Advent agreed to sell 30.0 million shares at 300.00 pence per share to institutional investors, leaving the private equity firm with a 24.1% stake in DFS, held through 51.4 million shares. Shares in DFS closed at 320.90p on Thursday.

UK manufacturing and industrial production data and trade balance are due at 0930 BST, while UK's NIESR gross domestic product estimate is due at 1500 BST.

"The CBI Industrial Trends survey and the manufacturing Purchasing Manager's Index output index both send the signal of some fall in manufacturing output in February," said analysts at French bank Societe Generale. "Accordingly, we predict that manufacturing production fell by 0.3% month-on-month in February after a rise by 0.7% month-on-month in January. Meanwhile, the trade deficit should stay within its narrow range, widening slightly from GBP3459 million to GBP3700 million in February".

In Asia on Friday, the Japanese Nikkei 225 index closed up 0.5%. In China, the Shanghai Composite ended down 0.8%, while the Hang Seng index in Hong Kong is down 0.2%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more
3 Nov 2022 09:18

LONDON MARKET OPEN: BT results disappoint; pound falls on Fed outlook

(Alliance News) - Stock prices in London opened lower on Thursday, as the pound fell against a strengthening dollar, after the Federal Reserve indicated that US interest rates are likely to reach higher levels than previously thought.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.